While Vir Biotech is best known for its work on infectious diseases, its developing cancer pipeline has delivered a partnership with Astellas that could be worth around $1.4 billion.
MOUNTAIN VIEW, Calif., Jan. 20, 2026 (GLOBE NEWSWIRE) -- RenovoRx, Inc. (RNXT) (“RenovoRx” or “the Company”) (Nasdaq: RNXT), a life sciences company developing innovative targeted oncology therapies, ...
A new drug combination to treat advanced recurring prostate cancer has shown remarkable results in a long-term trial, lowering the risk of death after eight years by 40.3%. What's more, the drug ...
Cancer drug in development at Ohio State could treat some of the most difficult forms of the illness
This weekend, thousands of riders will take to the streets for Pelotonia — the annual bike ride that raises millions of dollars for cancer research right here in Columbus. One of the projects ...
Add Yahoo as a preferred source to see more of our stories on Google. A biologist works on DNA extracted from cancer tissue in Oncompass Medicine's laboratory in Budapest, Hungary, June 2, 2021.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results